• 제목/요약/키워드: Acute phase response

검색결과 73건 처리시간 0.033초

DNA Ploidy and S-phase Fraction Analysis in Paediatric B-cell Acute Lymphoblastic Leukemia Cases: a Tertiary Care Centre Experience

  • Kumar, Banothu Kiran;Bhatia, Prateek;Trehan, Amita;Singh, Ajit Pal;Kaul, Deepak;Bansal, Deepak
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권17호
    • /
    • pp.7917-7922
    • /
    • 2015
  • DNA ploidy is an important prognostic parameter in paediatric B-ALL, but the significance of the S-phase fraction is unclear. In present study, DNA ploidy was assessed in 40 pediatric B-ALL cases by flow cytometry. The DI (DNA index) and percentage of cells in S-phase were calculated using Modfit software. Aneuploidy was noted in 26/40 (65%) cases. A DI of 1.10-1.6 (hyperdiploidy B) was noted in 20/40 (50%) and 6/40 (15%) had a DI>1.60 (triploid and tetraploid range). Some 14/40 (35%) cases had a diploid DI between 0.90-1.05. None of the cases had a DI <0.90 (hypodiploid) or in the 1.06-1.09 (hyperdiploid A) range. The mean S-phase fraction was 2.6%, with 24/40 (60%) having low and 16/40 (40%) high S-phase fractions. No correlation was noted with standard ALL risk and treatment response factors with DI values or S-phase data, except for a positive correlation of low S-phase with high NCI risk category (p=0.032). Overall frequency of hyperdiploidy in our cohort of B-ALL patients was very high (65%). No correlation between hyperdiploidy B and low TLC or common B-phenotype was observed in our study as 42% cases with DI 1.10-1.6 had TLC> $50{\times}10^9$ and 57.1% CD 10 negativity. The study also highlighted that S-phase fraction analysis does not add any prognostic information and is not a useful parameter for assessment in ALL cases. However, larger studies with long term outcome analysis are needed to derive definitive conclusions.

국소 진행된 자궁경부암의 방사선치료와 저용량 cisplatin 항암요법 동시치료시 급성독성 밀 초기반응 평가 (Low Dose Cisplatin as a Radiation Sensitizer in Management of Locally Advanced Scluamous Cell Carcinoma of the Uterine Cervix : Evaluation of Acute Toxicity and Early Response)

  • 김헌정;조영갑;김철수;김우철;이석호;노준규
    • Radiation Oncology Journal
    • /
    • 제17권2호
    • /
    • pp.113-119
    • /
    • 1999
  • 목적 :국소적으로 진행된 자궁경부암 환자에서 저용량의 Cisplatin을 방사선민감제로 사용하여 방사선치료와 동시 치료하였을 때의 급성독성 평가와 초기 반응을 평가하기 위하여 연구를 시행하였다. 대상 및 방법 : 본 연구는 1996년 12월부터 1999년 1월까지 FIGO Stage IIB-IIIB의 진행된 자궁경부암 환자 38명을 대상으로 하였다. 16명은 자궁경부암의 크기가 4cm이상인 환자들로 방사선 치료와 저용량의 cisplatin을 매일 동시에 치료 하였으며, 나머지 환자에선 방사선 치료 단독으로 치료하였다. 방사선치료는 골반강에 외부 방사선치료로 4500 cGy(3060cGy시행이후 midline block 추가), 자궁옅조직으로 침범이 있는 경우에는 자궁옅조직으로 방사선치료 부위를 줄여 900-1000cGy 추가치료를 시행하였고, 내부치료는 Ir$^{192}$고선량 근접 치료기(micro-Selectron HDR)로 6극회의 강 내조사(point "A"에 3000 to 3500cGy, 500cGy/fx, 2회/week)를 시행하였다. 방사선치료와 저용량의 cisplatin을 동시에 사용한 군에서는 방사선치료 첫날부터 방사선치료 20일째 되는 날까지 저용량의 cisplatin 10mg을 방사선치료 30분 전에 투여하였다. 급성독성의 평가는 expanded common toxicity criteria of the NCI Clinical Trial을 이용하였다. 초기반응의 평가는 방사선치료 종료이후 최소 4주이상의 추적조사가 가능한 사람들을 대상으로 시행되었다. 결과 : 급성독성 평가는 전체 38명에서 평가 가능하였으며, 방사선치료와 저용량의 cisplatin을 병용한 군에서 16명 중 6명(37.5$\%$)에서, 방사선 단독으로 치료한 군에서는 22명중 1명(6.2$\%$)에서 3등급 이상의 백혈구감소를 보였으며, 통계학적으로 의미있는 차이를 보였다 (P=0.030). 3등급 이상의 급성 위장간 독성은 저용량의 cisplatin을 병용한 군에서만 4명이 있었으나, 2-3일의 치료 중단이후 증상이 완화되어서 치료를 계속할 수 있었으며, 치료중 5kg이상의 체중감소는 방사선치료와 저용량의 cisplatin을 병용한 군에서는 16명중 3명(18.7$\%$), 방사선 단독으로 치료한 군에서는 22명중 2명(9.1$\%$)으로 통계학적으로 의미 있는 차이를 보이지 않았다(P=0.63). 초기반응은 추적조사가 4주 이상 가능하였던 34명을 대상으로 하였으며, 저용량의 cisplatin을 병용한 군에서 14명중 11명 (78$\%$), 방사선 단독으로 치료 군에서 20명중 16명(80$\%$)으로 통계학적으로는 의미있는 차이를 보이지 않았다(P=0.126). 결론 :국소 진행된 자궁경부암에 대한 방사선치료와 저용량의 cisplatin 병용요법 치료시 3등급 이상의 백혈구감소가 방사선치료 단독으로 치료시보다 많았으나, 1주 이하의 치료중단 이후 치료를 계속 할 수 있었으며, 4등급 이상의 백혈구감소와 치료에 의한 사망은 없었다. 초기반응에 대한 평가는 저용량의 cisplatin병용 군에서 4cm 이상의 자궁경부암을 가진 환자가 많음에도 불구하고 양 군에서 비슷한 정도의 반응을 보였으므로 진행된 자궁경부암의 치료에서 저용량의 cisplatin을 방사선민감제로 사용하여 치료결과의 향상을 기대할 수 있게 되었다. 따라서 저용량의 clsplatin과 방사선치료를 병용요법하였을 때의 치료효과를 판정하기 위해서는 phase III study가 필요하다.

  • PDF

가와사끼병 환자에서 분리한 CD14양성 세포에서 Toll-like Receptor-2의 발현 (Expression of Toll-like Receptor-2 on the Peripheral Blood Monocytes in Kawasaki Disease Patients)

  • 황대환;한정우;최경민;신경미;김동수
    • Clinical and Experimental Pediatrics
    • /
    • 제48권3호
    • /
    • pp.315-320
    • /
    • 2005
  • 목 적 : 본 연구에서는 가와사끼병에서 toll-like receptor(TLR)의 발현정도를 살펴 염증반응이 유발되기 시작하는 기전에 대해 접근하고자 하였다. 방 법 : 2003년 3월부터 8월까지 연세의료원에서 가와사끼병으로 진단 받은 환아 10명과 발열대조군 10명 및 정상대조군 10명의 말초혈액을 얻은 후 유세포분석기(flow cytometry)를 시행하여 CD14 양성인 단핵구에서의 TLR-2 발현정도를 측정하였다. 또한 말초 혈액 단핵구의 total RNA를 분리한 후 역전사중합효소 연쇄반응(RT-PCR)을 시행하여 TLR-2의 mRNA 발현을 살펴보았다. 결 과 : 환자군에서의 TLR-2 발현은 정상대조군보다 통계적으로 유의하게 증가되어 있었으나 임상경과에 따른 양상을 보면 급성기보다 아급성기에서 감소하였지만 통계적으로 유의한 차이는 보이지 않았고 환자군과 발열대조군의 TLR-2 발현도 의미있는 차이를 보이지 않았다. 또한 급성기 환자군의 말초혈액 단 핵구에서 TLR-2의 mRNA 발현이 증가되어 있었다. 결 론 : TLR-2의 발현은 가와사끼병 환자에서 정상대조군과 비교하여 증가되어 있었으며 이는 TLR 및 이를 통한 선천성 면역계(innate immunity)가 가와사끼병의 병인과 연관될 수 있음을 시사한다. 앞으로 TLR의 발현이 가와사끼병에서의 염증유발에 있어 구체적으로 어떤 역할을 하는지에 대한 연구가 더 필요할 것으로 사료된다.

용혈성 요독 증후군 (Hemolytic uremic syndrome)

  • 박혜원
    • Clinical and Experimental Pediatrics
    • /
    • 제50권10호
    • /
    • pp.931-937
    • /
    • 2007
  • The hemolytic uremic syndrome (HUS) is a rare disease of microangiopathic hemolytic anemia, low platelet count and renal impairment. HUS usually occurs in young children after hemorrhagic colitis by shigatoxin-producing enterohemorrhagic E. coli (D+HUS). HUS is the most common cause of acute renal failure in infants and young children, and is a substantial cause of acute mortality and morbidity; however, renal function recovers in most of them. About 10% of children with HUS do not reveal preceding diarrheal illness, and is referred to as D- HUS or atypical HUS. Atypical HUS comprises a heterogeneous group of thrombomicroangiopathy (TMA) triggered by non-enteric infection, virus, drug, malignancies, transplantation, and other underlying medical condition. Emerging data indicate dysregulation of alternative complement pathway in atypical HUS, and genetic analyses have identified mutations of several regulatory genes; i.e. the fluid phase complement regulator Factor H (CFH), the integral membrane regulator membrane cofactor protein (MCP; CD46) and the serine protease Factor I (IF). The uncontrolled activation of the complement alternative pathway results in the excessive consumption of C3. Plasma exchange or plasma infusion is recommended for treatment of, and has dropped the mortality rate. However, overall prognosis is poor, and many patients succumb to end-stage renal disease. Clinical presentations, response to plasma therapy, and outcome after renal transplantation are influenced by the genotype of the complement regulators. Thrombotic thrombocytopenic purpura (TTP), another type of TMA, occurs mainly in adults as an acquired disease accompanied by fever, neurologic deficits and renal abnormalities. However, less frequent cases of congenital or hereditary TTP associated with ADAMTS-13 (a disintegrin and metalloprotease, with thrombospondin 1-like domains 13) gene mutations have been reported, also. Recent advances in molecular genetics better allow various HUS to be distinguished on the basis of their pathogenesis. The genetic analysis of HUS is important in defining the underlying etiology, predicting the genotype-related outcome and optimizing the management of the patients.

자기공명분석기를 이용한 통증관리 (Clinical Study of Acute and Chronic Pain by the Application of Magnetic Resonance Analyser $I_{TM}$)

  • 박욱;진희철;조명현;윤석준;이진승;이정석;최석환;김성열
    • The Korean Journal of Pain
    • /
    • 제6권2호
    • /
    • pp.192-198
    • /
    • 1993
  • In 1984, a magnetic resonance spectrometer(magnetic resonance analyser, MRA $I_{TM}$) was developed by Sigrid Lipsett and Ronald J. Weinstock in the USA, Biomedical applications of the spectrometer have been examined by Dr. Hoang Van Duc(pathologist, USC), and Nakamura, et al(Japan). From their theoretical views, the biophysical functions of this machine are to analyse and synthesize a healthy tissue and organ resonance pattern, and to detect and correct an abnormal tissue and organ resonance pattern. All of the above functions are based on Quantum physics. The healthy tissue and organ resonance patterns are predetermined as standard magnetic resonance patterns by digitizing values based on peak resonance emissions(response levels or high pitched echo-sounds amplified via human body). In clinical practice, a counter or neutralizing resonance pattern calculated by the spectrometer can correct a phase-shifted resonance pattern(response levels or low pitched echo-sounds) of a diseased tissue and organ. By administering the counter resonance pattern into the site of pain and trigger point, it is possible to readjust the phase-shifted resonance pattern and then to alleviate pain through regulation of the neurotransmitter function of the nervous system. For assessing clinical effectiveness of pain relief with MRA $I_{TM}$ this study was designed to estimate pain intensity by the patient's subjective verbal rating scale(VRS such as graded to no pain, mild, moderate and severe) before application of it, to evaluate an amount of pain relief as applied the spectrometer by the patients subjective pain relief scale(visual analogue scale, VAS, 0~100%), and then to observe a continuation of pain relief following its application for managing acute and chronic pain in the 102 patients during an 8 months period beginning March, 1993. An application time of the spectrometer ranged from 15 to 30 minutes daily in each patient at or near the site of pain and trigger point when the patient wanted to be treated. The subjects consisted of 54 males and 48 females, with the age distribution between 23~40 years in 29 cases, 41~60 years in 48 cases and 61~76 years in 25 cases respectively(Table 1). The kinds of diagnosis and the main site of pain, the duration of pain before the application, and the frequency of it's application were recorded on the Table 2, 3 and 4. A distinction between acute and chronic pain was defined according to both of the pain intervals lasting within and over 3 months. The results of application of the spectrometer were noted as follows; In 51 cases of acute pain before the application, the pain intensities were rated mild in 10 cases, moderate in 15 cases and severe in 26 cases. The amounts of pain relief were noted as between 30~50% in 9 cases, 51~70% in 13 cases and 71~95% in 29 cases. The continuation of pain relief appeared between 6~24 hours in two cases, 2~5 days in 10 cases, 6~14 days in 4 cases, 15 days in one case, and completely relived of pain in 34 cases(Table 5~7). In 51 cases of chronic pain before the application, the pain intensities were rated mild in 12 cases, moderate in l8 cases and severe in 21 cases. The amounts of pain relief were noted as between 0~50% in 10 cases, 51~70% in 27 cases and 71~90% in 14 cases. The continuation of pain relief appeared to have no effect in two cases. The level of effective duration was between 6~12 hours in two cases, 2~5 days in 11 cases, 6~14 days in 14 cases, 15~60 days in 9 cases and in 13 cases the patient was completely relieved of pain(Table 5~7). There were no complications in the patients except a mild reddening and tingling sensation of skin while applying the spectrometer. Total amounts of pain relief in all of the subjects were accounted as poor and fair in 19(18.6%) cases, good in 40(39.2%) cases and excellent in 43(42.2%) cases. The clinical effectiveness of MRA $I_{TM}$ showed variable distributions from no improvements to complete relief of pain by the patient's assessment. In conclusion, we suggest that MRA $I_{TM}$ may be successful in immediate and continued pain relief but still requires several treatments for continued relief and may be gradually effective in pain relief while being applied repeatedly.

  • PDF

Gene Expression Profiling of 6-MP (6-mercaptopurine) in Liver

  • Kim Hyung-Lae;Kim Han-Na;Lee Eun-Ju
    • Genomics & Informatics
    • /
    • 제4권1호
    • /
    • pp.16-22
    • /
    • 2006
  • The KFDA (Korea Food & Drug Administration) has performed a collaborative toxicogenomics project since 2003. Its aim is to construct a toxicology database of 12 compounds administered to mice at initial phase. We chose 6-MP (6-mercaptopurine) which has been used in the treatment of childhood leukemia. It was administered at low (0.224 mg/kg) and at high (2.24 mg/kg) dose (5 mice per group) intraperitonealy to the postnatal 6 weeks mice, then the serum and liver were collected at the indicated time (6, 24 and 72 h) after scarification. Serum biochemical markers for liver toxicity were measured and histopathologic studies also were carried out. The gene expression profiling was carried out by using Applied Biosystems 1700 Full Genome Expression Mouse. By self-organization maps (SOM), we identified groups with unique gene expression patterns, some of them are supposed to be related to 6-MP induced toxicity, including lipid metabolism abnormality, inflammatory response, oxidative stress, ATP depletion and cell death. The potential toxic effects appearing as gene expression changes are dependent of the time of 6-MP but independent of the dosage of it. This study would contribute to establishment of international database as well as national one about hepatotoxicity.

헵토글로빈 측정을 위한 수정미소저울 바이오센서 개발 (QCM biosensor for the determination of haptoglobin)

  • 김성일;이현정;박순혁;방현수;이진아;최석정
    • 센서학회지
    • /
    • 제16권2호
    • /
    • pp.132-141
    • /
    • 2007
  • The purpose this research is to develop QCM (quartz crystal microbalance) biosensor for the determination of haptoglobin. Haptoglobin is an acute-phase protein with a hemoglobin-binding activity and has a potential to be used as a biomarker for infection or cancer. Haptoglobin level in milk has been used for the diagnosis of cow mastitis. In this study, anti-bovine haptoglobin antibody or bovine hemoglobin was chemically immobilized on the surface of the QCM, and the resulting sensor chips were tested for their response to samples containing haptoglobin at different concentrations. Concentration dependent frequency change was observed with both of the sensor chips. Especially, the sensor chip containing anti-bovine haptoglobin antibody showed sufficient sensitivity in the concentrations typically observed in the cows with mastitis.

Efficacy of Oral Korean Red-ginseng on sCRP and Soreness after Muscle Damage

  • NA, Hyun-Jong
    • 대한한의학회지
    • /
    • 제26권4호
    • /
    • pp.39-45
    • /
    • 2005
  • Objectives: The study investigated the efficacy of oral Korean red-ginseng (RG) on sCRP response mediated by eccentric contraction-induced muscle damage and discussed its mechanism. Methods: Nineteen healthy young subjects (aged 24.4$\pm$2.07 yr) volunteered for this double blind test. They were classified into either the RG group (N=10) or placebo (P) group (N=9) during the 10-d experimental protocol. Blood samples were collected on T1 (baseline), T1 (1h), T2 (1d), T3 (2d) and T4 (3d) after eccentric contraction-induced injury on the seventh day. Statistical analyses were conducted using nonparametric methods (p<0.05). Results: The RG group increased sCRP more than P group and didn't increase soreness peak at T2, not significant. There were no correlations between soreness intensity and sCRP. Oral RG had little efficacy for reducing sCRP at the muscle damage-mediated acute phase; rather, it increased because of its proinflammatory cytokine production. Conclusions: Oral RG could stimulate proinflammatory cytokine production, and occasionally bal-pyo-beob could be helpful for the efficient recovery of muscle injury.

  • PDF

건강걷기, 건강걷기와 식이 교육이 고중성지방혈증 비만 여성의 C-reactive protein에 미치는 영향 (Effects of Brisk Walking and Brisk Walking Plus Diet on C-reactive Protein in Obese Women with Hypertriglycemia)

  • 이미라;김완수
    • 성인간호학회지
    • /
    • 제18권4호
    • /
    • pp.660-667
    • /
    • 2006
  • Purpose: The purpose of this study was to investigate the effects of 12-week brisk walking and brisk walking plus diet program on C-Reactive Protein(CRP) in middle-aged obese hypertriglycemic($triglyceride{\geq}150mg/d{\ell}$) Korean women. Method: The subjects were 16 obese ($BMI{\geq}25$) hypertriglycemic middle-aged women (7 for brisk walking group, 9 for brisk walking plus diet group) who participated in a health promotion program at one public health center. Initially the brisk walking intervention consisted of walking for 20 minutes/day at an intensity of 40 to 50% of heart rate reserve(HRR) for 3 days/week and progressed to 50 minutes/day, 60 to 70% of their HRR, and 6 days/week. The diet intervention consisted of 60 minutes of group education and 20 to 30 minutes of individual counseling with a nutritionist every week. Data were analyzed with SPSS PC program. Results: There was no significant reduction in CRP levels in both brisk walking (Z=-1.70, p=0.088) and brisk walking plus diet group(Z=-0.31, p=0.752). In brisk walking only group, CRP levels were increased after the intervention. Conclusion: Brisk walking could increase the level of CRP when it is in the course of progression and diet could decrease the acute phase inflammatory response.

  • PDF

Inhibitory effect of epigallocatechin from Camellia sinensis leaves against pro-inflammatory mediator release in macrophages

  • Cho, Jun-Hyo;Hong, Eun-Jin;Cho, Young-Je
    • Journal of Applied Biological Chemistry
    • /
    • 제60권3호
    • /
    • pp.199-205
    • /
    • 2017
  • To investigate the anti-inflammatory activity of natural products, we determined the anti-inflammatory activity of purified epigallocatechin (EGC) from Camellia sinensis leaves. In the present study, we found that EGC inhibited the production of proinflammatory mediators (IL-6, TNF-${\alpha}$, NO, and $PGE_2$) in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells. Suppression of IL-6 seems to be at least partly attributable to the inhibitory effect of EGC. TNF-${\alpha}$ is a major cytokine produced by LPS-induced macrophages, and they have a wide variety of biological functions including regulation of inflammation. The inhibition of IL-6 and TNF-${\alpha}$ production by EGC may downregulate the acute-phase response to LPS, thereby reducing LPS-induced inflammation. In addition to IL-6 and TNF-${\alpha}$, EGC effectively reduced the production of other key inflammatory mediators, including NO and $PGE_2$. The inhibitory effect of EGC on NO and $PGE_2$ production was supported by the suppression of inducible nitric oxide synthase and COX-2 at protein levels. These results support the traditional use of EGC in the alleviation of various inflammation-associated diseases and suggest that EGC might be useful in the development of new functional foods for inflammatory diseases.